Notable Projects

• Detection of JAK2, CALR and MPL gene mutations and their relevance in diagnosing and handling of myeloproliferative neoplasms in patients treated in hospitals in Medellín between 2017-2018.
• Detección de mutaciones en el dominio tirosina quinasa de BCR-ABL1 en pacientes colombianos con leucemia mieloide crónica LMC, resistentes al imatinib (Detection of BCR-ABL1 tyrosine kinase domain mutations in chronic myeloid leukemia patients with Imatinib resistance in Colombia) Rev Colomb Cancerol 2018;22(1):817.
• Prevalencia de mutaciones de FLT3en leucemia mieloblástica aguda: experiencia multicéntrica en Latinoamérica (Prevalence of FLT3 mutations in acute myeloblastic leukemia: multicenter experience in Latin America.) Rev. Hematol Mex 2013; 14 (Supl. 1): S79-S107.
• Genetic and epigenetic characterization in individuals with colorectal cancer. Committee for Research Development (CODI). Programmatic.

Main Research Results

• Establishment of new genetic tests for accurate diagnosis, monitoring, and prognosis of patients with leukemia and solid tumors.
• In this regard, we have received financial support for the amount of 1,45 billion COP since 2012 for the children’s cancer program.
• We have contributed to the research field with knowledge about the histopathology of leukemias and solid tumors in Colombian patients. These projects have allowed undergraduate and graduate human talent to be trained.
• Regarding clinical genetics, patients with genetic syndromes have been in consultation, and the corresponding counseling was provided.
• We offer undergraduate degree courses where research results are shared.
• The group has participated in congresses on Genetics and Hematology.

Research Portafolio